Stimulate-and-retain hydrogel strategy integrating oncolytic virus and oxaliplatin for dual ICD-inducing antitumor immunity.

Zhang D, Chen A, Huang H, Li W, Huang Q, Chen H, Zhang J, Yang L, Sun C, Zeng X

Open source

DOI
10.1016/j.apsb.2026.07.040
Published
2026 Oct
Container
Acta pharmaceutica Sinica. B
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.apsb.2026.07.040,
  title = {Stimulate-and-retain hydrogel strategy integrating oncolytic virus and oxaliplatin for dual ICD-inducing antitumor immunity.},
  author = {Zhang D and Chen A and Huang H and Li W and Huang Q and Chen H and Zhang J and Yang L and Sun C and Zeng X},
  year = {2026},
  journal = {Acta pharmaceutica Sinica. B},
  doi = {10.1016/j.apsb.2026.07.040},
  url = {https://doi.org/10.1016/j.apsb.2026.07.040}
}

RIS

TY  - JOUR
TI  - Stimulate-and-retain hydrogel strategy integrating oncolytic virus and oxaliplatin for dual ICD-inducing antitumor immunity.
AU  - Zhang D
AU  - Chen A
AU  - Huang H
AU  - Li W
AU  - Huang Q
AU  - Chen H
AU  - Zhang J
AU  - Yang L
AU  - Sun C
AU  - Zeng X
PY  - 2026
JO  - Acta pharmaceutica Sinica. B
DO  - 10.1016/j.apsb.2026.07.040
UR  - https://doi.org/10.1016/j.apsb.2026.07.040
ER  - 

APA

D, Z., A, C., H, H., W, L., Q, H., H, C., J, Z., L, Y., C, S., & X, Z. (2026). Stimulate-and-retain hydrogel strategy integrating oncolytic virus and oxaliplatin for dual ICD-inducing antitumor immunity.. Acta pharmaceutica Sinica. B. https://doi.org/10.1016/j.apsb.2026.07.040

Source records